Skip to content

Effect of anticoagulant on prognosis of patients with sepsis-induced coagulopathy: A multicenter, prospective cohort study

Effect of anticoagulant on prognosis of patients with sepsis-induced coagulopathy: A multicenter, prospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114751
Enrollment
Unknown
Registered
2025-12-17
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis-induced Coagulopathy, SIC

Interventions

Sponsors

The Second Affiliated Hospital of Xi’an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years; 2.Meeting the diagnostic criteria for "Sepsis and Septic Shock as defined by the Third International Consensus Definitions" within 6 hours of ICU admission; 3.Meeting the diagnostic criteria for Sepsis-Induced Coagulopathy (SIC) as defined by the ISTH within 6 hours of ICU admission; 4.TAT/PIC level > 5 within 6 hours of ICU admission; 5.Expected ICU length of stay > 72 hours; 6.Informed consent obtained from the patient or legally authorized representative.

Exclusion criteria

Exclusion criteria: 1.Patients with an ISTH overt DIC score >= 5 (meeting the diagnostic criteria for overt DIC) within 24 hours after SIC diagnosis and prior to the initiation of anticoagulant therapy must be immediately excluded from the study; 2.History of major surgery or severe trauma within 72 hours prior to ICU admission; presence of severe bleeding tendency, intracranial hemorrhage, or uncontrolled active major bleeding. 3.Comorbidities with irreversible end-stage diseases (e.g., advanced malignancy, end-stage liver disease); pregnancy or lactation; long-term use of high-dose immunosuppressive agents; severe psychiatric disorders; history of alcohol abuse. 4.Use of anticoagulant medications within 48 hours prior to SIC diagnosis.

Design outcomes

Primary

MeasureTime frame
ICU mortality;

Secondary

MeasureTime frame
Major bleeding;CRP Change;Disseminated Intravascular Coagulation (DIC) Onset;TAT/PIC Change;28-day mortality;

Countries

China

Contacts

Public ContactJiamei Li

The Second Affiliated Hospital of Xi’an Jiaotong University

18792478857@163.com+86 29 8767 9633

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026